Heba F Salem1, Rasha M Kharshoum1, Sara M Awad2, Mai Ahmed Mostafa3, Heba A Abou-Taleb3. 1. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. 2. Department of Dermatology, Venereology and Andrology, Assiut University Hospital, Assiut, Egypt. 3. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Nahda University (NUB), Beni-Suef, Egypt.
Abstract
AIM: Retinyl palmitate (RP), the most stable vitamin A derivative, is used to treat photoaging and other skin disorders. The need to minimize the adverse effects of topical drug administration has led to an enhanced interest in loading RP on ethosomes for topical drug delivery. The aim of the current study was to prepare and compare the performance of RP decorated ethosomal hydrogel with tretinoin cream in the treatment of acne vulgaris as an approach to improve drug efficacy and decrease its side effects. METHODS: RP-loaded ethosomes were prepared using the injection sonication technique. A Box-Behnken design using Design Expert® software was used for the optimization of formulation variables. Particle size, zeta potential (ZP), entrapment efficiency percent (EE%), % drug release, and permeation over 24 h of different formulations were determined. The optimal formulation was incorporated into a hydrogel. Finally, the efficacy and tolerability of the optimized RP ethosomal hydrogel were clinically evaluated for acne treatment using a split-face comparative clinical study. RESULTS: The optimized ethosomal RP showed particle size of 195.8±5.45 nm, ZP of -62.1±2.85 mV, EE% of 92.63±4.33%, drug release % of 96.63±6.81%, and drug permeation % of 85.98 ±4.79%. Both the optimized RP ethosomal hydrogel and tretinoin effectively reduced all types of acne lesions (inflammatory, non-inflammatory, and total lesions). However, RP resulted in significantly lower non-inflammatory and total acne lesion count than the marketed tretinoin formulation. Besides, RP-loaded ethosomes showed significantly improved tolerability compared to marketed tretinoin with no or minimal skin irritation symptoms. CONCLUSION: RP ethosomal hydrogel is considerably effective in controlling acne vulgaris with excellent skin tolerability. Therefore, it represents an interesting alternative to conventional marketed tretinoin formulation for topical acne treatment.
AIM: Retinyl palmitate (RP), the most stable vitamin A derivative, is used to treat photoaging and other skin disorders. The need to minimize the adverse effects of topical drug administration has led to an enhanced interest in loading RP on ethosomes for topical drug delivery. The aim of the current study was to prepare and compare the performance of RP decorated ethosomal hydrogel with tretinoin cream in the treatment of acne vulgaris as an approach to improve drug efficacy and decrease its side effects. METHODS: RP-loaded ethosomes were prepared using the injection sonication technique. A Box-Behnken design using Design Expert® software was used for the optimization of formulation variables. Particle size, zeta potential (ZP), entrapment efficiency percent (EE%), % drug release, and permeation over 24 h of different formulations were determined. The optimal formulation was incorporated into a hydrogel. Finally, the efficacy and tolerability of the optimized RP ethosomal hydrogel were clinically evaluated for acne treatment using a split-face comparative clinical study. RESULTS: The optimized ethosomal RP showed particle size of 195.8±5.45 nm, ZP of -62.1±2.85 mV, EE% of 92.63±4.33%, drug release % of 96.63±6.81%, and drug permeation % of 85.98 ±4.79%. Both the optimized RP ethosomal hydrogel and tretinoin effectively reduced all types of acne lesions (inflammatory, non-inflammatory, and total lesions). However, RP resulted in significantly lower non-inflammatory and total acne lesion count than the marketed tretinoin formulation. Besides, RP-loaded ethosomes showed significantly improved tolerability compared to marketed tretinoin with no or minimal skin irritation symptoms. CONCLUSION: RP ethosomal hydrogel is considerably effective in controlling acne vulgaris with excellent skin tolerability. Therefore, it represents an interesting alternative to conventional marketed tretinoin formulation for topical acne treatment.
Authors: Diane M Thiboutot; Brigitte Dréno; Abdullah Abanmi; Andrew F Alexis; Elena Araviiskaia; Maria Isabel Barona Cabal; Vincenzo Bettoli; Flordeliz Casintahan; Steven Chow; Adilson da Costa; Tam El Ouazzani; Chee-Leok Goh; Harald P M Gollnick; Minerva Gomez; Nobukazu Hayashi; Maria Isabel Herane; Juan Honeyman; Sewon Kang; Lajos Kemeny; Raj Kubba; Julien Lambert; Alison M Layton; James J Leyden; Jose Luis López-Estebaranz; Nopadon Noppakun; Falk Ochsendorf; Cristina Oprica; Beatriz Orozco; Montserrat Perez; Jaime Piquero-Martin; Jo-Ann See; Dae Hun Suh; Jerry Tan; Vicente Torres Lozada; Patricia Troielli; Leihong Flora Xiang Journal: J Am Acad Dermatol Date: 2017-11-08 Impact factor: 11.527
Authors: Heba M Aboud; Mohammed H El Komy; Adel A Ali; Shahira F El Menshawe; Ahmed Abd Elbary Journal: AAPS PharmSciTech Date: 2016-01-07 Impact factor: 3.246
Authors: Virginia Garofalo; Maria Vittoria Cannizzaro; Sara Mazzilli; Luca Bianchi; Elena Campione Journal: Clin Cosmet Investig Dermatol Date: 2019-05-15